Anaphylaxis in America™ is an independent research project of AAFA. The study was designed by AAFA along with a leading group of health, medical and research experts to assess prevalence, as well as to better understand patient, public and physician attitudes and behaviors regarding anaphylaxis. Three independent nationwide surveys were conducted– a public survey, a patient survey and a physician survey. This project was sponsored by Sanofi US.
Patient and Public Surveys
NEARLY 1-IN-50 AMERICANS AT-RISK OF SEVERE ALLERGIC REACTIONS
Anaphylaxis is More Common the Many Thought, Most Patients are Not Prepared
A novel study by the Asthma and Allergy Foundation of America (AAFA) published in the Journal of Allergy and Clinical Immunology (JACI) finds that severe life-threatening allergic reactions – anaphylaxis – are common in the U.S. According to the peer-reviewed study, anaphylaxis very likely occurs in nearly 1-in-50 Americans (1.6%), and the rate is probably higher, close to 1-in-20 (5.1%).
The article, Anaphylaxis in America: The Prevalence and Characteristics of Anaphylaxis in the United States, based on AAFA’s study of the same name, provides one of the most reliable estimates to-date of the prevalence of severe, life-threatening allergies in the general population. It is also helping experts understand how the public, patients and caregivers think, feel and behave regarding anaphylaxis. See the links below to the article and 2014 Press Release to learn more about the results of the public and patient surveys.
DEFICIENCIES IN CARE FOR PATIENTS WITH SEVERE ALLERGIC REACTIONS
Survey Exposes Knowledge Gaps Among Primary Care and Emergency Physicians
Another paper from the Asthma and Allergy Foundation of America (AAFA) finds significant differences among physician groups in knowledge and attitudes regarding anaphylaxis. In a Letter to the Editor published last week in the Journal of Allergy and Clinical Immunology (JACI), the authors of the study summarized results from the physician survey, which revealed startling deficiencies among physician groups.
The letter, Anaphylaxis in America: A National Physician Survey, based on AAFA’s study of the same name, provides an in-depth look at the experience with and knowledge of anaphylaxis among 5 physician groups: allergy/immunology specialists (50% with pediatric and 50% with internal medicine training), emergency physicians, family practitioners, and pediatricians. It also provides insights into physicians’ awareness and attitudes regarding anaphylaxis. See the links below to the letter and 2015 Press Release to learn more about the results of the physician survey.
For more information about this study or to request a copy of the full article, please contact email@example.com.